Diamedica Therapeutics Inc (DMAC)

Investing Cash Flow

-$12.08M

TTM · Period ending: · USD

DMAC logo

DMAC Investing Cash Flow

Latest reported-$12.08M
DMAC TTM Cash from Investing (-$296.17K → -$12.08M)
High-resolution chart · PNG

DMAC investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Diamedica Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-12,081,409
-11,367,409
-2,631,409
-5,421,409
15,199,000
10,978,000
8,564,000
9,483,000
16,264,000
-16,600,000
-18,299,000
-19,699,000
-18,823,000
11,833,000
11,538,000
-1,875,000
-16,775,000
-18,314,000
-20,537,000
-11,181,000
-12,353,000
-10,842,000
-16,134,000
-15,793,000
1,207,000
1,719,000
-3,908,000
-4,902,888
-7,924,449
-10,946,092
-50,000
-78,413
-60,768
-53,908
-22,000
-10,678
-9,090
-9,797
-6,893
-5,329
-4,078
-362
-5,388
-1,719
-4,160
-16,567
-31,328
-63,904
-97,281
-116,762
-134,270
-119,766
-94,047
-92,154
-63,372
-93,963
-109,527
-79,776
-79,310
-48,120
-32,950
-57,056
-57,615
-67,476
-68,287
-74,723
-92,089
-62,506
-67,017
-83,313
-85,263
-142,612
-232,065
-274,751
-296,169
-279,516
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.